A

Axsome Therapeutics
D

AXSM

137.720
USD
8.55
(6.62%)
مغلق
حجم التداول
58,878
الربح لكل سهم
-3
العائد الربحي
-
P/E
-23
حجم السوق
6,715,971,301
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    -0.350
    (-1.73%)
    19.940 USD
    AMGN
    AMGN
    5.10
    (1.71%)
    303.15 USD
    BIIB
    BIIB
    3.560
    (2.60%)
    140.630 USD
    B
    BMRN
    -0.525
    (-0.76%)
    68.215 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    L
    LGND
    -1.350
    (-1.11%)
    120.680 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار
المقالات

العنوان: Axsome Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.